Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.24
-0.08 (-1.60%)
Apr 6, 2026, 1:13 PM EDT - Market open
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $170.58 million as of April 6, 2026. Its market cap has increased by 37.62% in one year.
Market Cap
170.58M
Enterprise Value
60.31M
1-Year Change
37.62%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $170.58M, a decrease of -51.92%. That is a compound annual growth rate of -23.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 173.35M | -9.96% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corbus Pharmaceuticals Holdings | 180.38M |
| ProQR Therapeutics | 180.17M |
| Galectin Therapeutics | 175.76M |
| Unicycive Therapeutics | 174.90M |
| Protalix BioTherapeutics | 173.23M |
| Achieve Life Sciences | 171.97M |
| Milestone Pharmaceuticals | 169.26M |
| Connect Biopharma Holdings | 169.00M |